DHL and Octapharma open cold-chain logistics centre in Germany

By Dan Stanton

- Last updated on GMT

New logistics centre in Leipzig has two temperature controlled areas
New logistics centre in Leipzig has two temperature controlled areas
In a venture with plasma products manufacturer Octapharma, DHL has opened a €3.4m ($4.4m) cold-chain logistics centre in Germany for the pharma and life sciences industries.

According to Raluca Witowski, a spokesperson for DHL Global Forwarding (DGF) - the air and ocean freight wing of Deutsche Post DHL - the site already has around 350 customers but the 550m2​ GDP-certified facility which opened its doors yesterday offers the transportation and warehousing of active and passive temperature controlled products.

The Centre, located in Leipzig, Germany, was developed in part by the biopharma company Octapharma. The Switzerland-based blood plasma manufacturer is one of DGF’s “key customers,”​ Witowski told us, and Octapharma’s involvement came due to needing a logistics partner in the proximity of their own facility in Dessau, 50 km away from the new facility.

However, the Centre will also bring benefit to other firms in the life science and healthcare industries. “The strategic location of the Centre connects seamlessly into the worldwide airfreight network of 150 life science and healthcare stations in 25 countries, offering great opportunities for customers,”​ Witowski added.

Cold-Chain security

The Leipzig plant creates 30 new jobs and forms part of the DHL Thermonet, a network formed in 2013​ which uses DHL’s SmartSensor RFID technology to constantly monitor temperatures of shipments in transit.

The importance of ensuring temperature control during the movement of drugs was recently highlighted when Phase III trial results of Ampio Biopharmaceuticals’ lead candidate Ampion were delayed​ due to trial material being damaged when shipping temperatures fell below the 15°C minimum required. The firms share price fell 19% following the announcement.

“Providing quality service to life-saving products is a big responsibility, and temperature-control is therefore a critical point in the logistics chain,”​ Witowski said. “The pharmaceutical products have to be transported quickly, safely and in a stable, temperature-controlled environment to the customers.”

DGF, which was not the logistics firm implicated in the Ampio case, is therefore providing two temperature controlled areas at the new site, one for pharmaceutical products that must be kept at a constant temperature between 2 to 8 degrees and a second area for temperature between 15 to 25 degrees.

“The facilities are equipped with numerous temperature and humidity sensors that immediately sound an alarm should conditions fall outside of established parameters. The centre also has a loading/ unloading area where the temperature is maintained at 15°C.”

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Follow us

Products

View more

Webinars